Acromegaly and Gigantism- Epidemiology Forecast To 2023

Publisher Name :
Date: 01-Apr-2017
No. of pages: 51
Price : Single User: US $ 2750  US $ 2338 Corporate User: US $ 8250  US $ 5775
This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's"Acromegaly and Gigantism- Epidemiology Forecast to 2023" Report provides an overview of the epidemiology trends of Acromegaly in seven major markets (US, France, Germany, Italy, Spain, UK and Japan) and Gigantism in six major markets (US, United Kingdom, France, Germany, Italy and Spain). It includes 10 years epidemiology historical and forecasted data of prevalent cases of Acromegaly and Gigantism by age, sex and sub populations. The Report also discusses the prevailing risk factors, disease burden with special emphasis.

Acromegaly is a rare but serious hormonal disorder caused by excessive growth hormone (GH) in the blood in adults. Acromegaly in adults occurs mainly in middle-aged men and women. In This condition, the bones increase in size, including those of the hands, feet and face. Acromegaly is uncommon and physical changes occur gradually thus the condition often isn't recognized immediately and if not treated promptly, it can lead to serious illness and even become life-threatening. According to DelveInsight's estimates, the prevalent cases of Acromegaly in the 7 MM are expected to increase with a CAGR of 0.72% for the forecast period i.e., 2013-2023.

Gigantism is excessive production of GH in children which is extremely rare and leads to exaggerated bone growth and an abnormal increase in height. It results from high linear growth due to excessive action of insulin like growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the growth plate cartilage fuses in adulthood. According to DelveInsight's estimates, prevalent cases of Gigantism in the 6 MM are expected to increase with a CAGR of 2% and Acromegaly in the 7 MM are expected to increase with a CAGR of 0.72% for the forecast period i.e., 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Key Coverage and Benefits:

The report will help in developing business strategies by understanding the trends shaping and driving the global epidemiology of Acromegaly and Gigantism.

Identifying prevalent patient populations as well as risk factors in the global Acromegaly and Gigantism market will help to improve product design, pricing, and launch plans.

This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Acromegaly and Gigantism- Epidemiology Forecast To 2023

Table of Contents

Report Introduction
Acromegaly and Gigantism: Overview
Causes
Signs and Symptoms
Risk Factors
Pathophysiology
Diagnosis
Treatment
Epidemiology of Acromegaly in 7MM
Epidemiology and Patient Population
Assumptions and Caveats
Prevalent Population of Acromegaly in 7MM
United States
Sex Specific Prevalence of Acromegaly in United States
Age- Specific Prevalence of Acromegaly in United States
Europe
United Kingdom
Sex Specific Prevalence of Acromegaly in United Kingdom
Age- Specific Prevalence of Acromegaly in United Kingdom
France
Sex Specific Prevalence of Acromegaly in France
Age- Specific Prevalence of Acromegaly in France
Italy
Sex Specific Prevalence of Acromegaly in Italy
Age- Specific Prevalence of Acromegaly in Italy
Spain
Sex Specific Prevalence of Acromegaly in Spain
Age- Specific Prevalence of Acromegaly in Spain
Germany
Sex Specific Prevalence of Acromegaly in Germany
Age- Specific Prevalence of Acromegaly in Germany
Japan
Sex Specific Prevalence of Acromegaly in Japan
Age- Specific Prevalence of Acromegaly in Japan
Epidemiology of Gigantism in 6MM
Epidemiology and Patient Population
Prevalent Population of Gigantism in 6MM
United States
Europe
United Kingdom
France
Italy
Spain
Germany
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Prevalent Population of Acromegaly in 7MM (2013-2023)
Table 2: Prevalent Population of Acromegaly in United States (2013-2023)
Table 3: Sex Specific Prevalence of Acromegaly in United States (2013-2023)
Table 4: Age-Specific Prevalence of Acromegaly in United States (2013-2023)
Table 5: Prevalent Population of Acromegaly in United Kingdom (2013-2023)
Table 6: Sex Specific Prevalence of Acromegaly in United Kingdom (2013-2023)
Table 7: Age-Specific Prevalence of Acromegaly in United Kingdom (2013-2023)
Table 8: Prevalent Population of Acromegaly in France (2013-2023)
Table 9: Sex Specific Prevalence of Acromegaly in France (2013-2023)
Table 10: Age-Specific Prevalence of Acromegaly in France (2013-2023)
Table 11: Prevalent Population of Acromegaly in Italy (2013-2023)
Table 12: Sex Specific Prevalence of Acromegaly in Italy (2013-2023)
Table 13: Age-Specific Prevalence of Acromegaly in Italy (2013-2023)
Table 14: Prevalent Population of Acromegaly in Spain (2013-2023)
Table 15: Sex Specific Prevalence of Acromegaly in Spain (2013-2023)
Table 16: Age-Specific Prevalence of Acromegaly in Spain (2013-2023)
Table 17: Prevalent Population of Acromegaly in Germany (2013-2023)
Table 18: Sex Specific Prevalence of Acromegaly in Germany (2013-2023)
Table 19:Age-Specific Prevalence of Acromegaly in Germany (2013-2023)
Table 20: Prevalent Population of Acromegaly in Japan (2013-2023)
Table 21: Sex Specific Prevalence of Acromegaly in Japan (2013-2023)
Table 22:Age-Specific Prevalence of Acromegaly in Japan (2013-2023)
Table 23: Prevalent Population of Gigantism in 6MM (2013-2023)
Table 24: Prevalent Population of Gigantism in United States (2013-2023)
Table 25: Prevalent Population of Gigantism in United Kingdom (2013-2023)
Table 26: Prevalent Population of Gigantism in France (2013-2023)
Table 27: Prevalent Population of Gigantism in Italy (2013-2023)
Table 28: Prevalent Population of Gigantism in Spain (2013-2023)
Table 29: Prevalent Population of Gigantism in Germany (2013-2023)

List of Figures

Disease Overview
Prevalence
Incidence
Risk Factors
Epidemiology
Epidemiology in 7MM
Patient Populations
Diagnosed Patients
Forecast
Epidemiology Forecast
Epidemiology Forecast in 7MM
Epidemiology Forecast, 2023
Prevalent Cases
Incident Cases
Treated patients/population
Acromegaly
Gigantism
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Varicose Vein Treatment Market Research Report 2017
    Published: 22-Jun-2017        Price: US 2900 Onwards        Pages: 112
    In this report, the global Varicose Vein Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Varicose Vein Treatment in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Ch......
  • Global Vasculitis Treatment Market 2017-2021
    Published: 21-Jun-2017        Price: US 3500 Onwards        Pages: 78
    Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. The body's immune system attacks the blood vessels, which results in inflammation. When this inflammation occurs, the walls of the affected blood vessels get thicker and the passages through which the blood flows get narrower, which reduces the amount of blood and oxygen delivered to vital organs. The analysts forecast global vasculitis treatment market to grow at a CAGR of 4.20 % during the period 201......
  • Global Anti-inflammatory Therapeutics Market Research Report 2017
    Published: 21-Jun-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Anti-inflammatory Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anti-inflammatory Therapeutics in these regions, from 2012 to 2022 (forecast), covering - North America - Euro......
  • EMEA (Europe, Middle East and Africa) Brachytherapy Afterloaders, Brachytherapy Seeds Market Report 2017
    Published: 14-Jun-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the EMEA Brachytherapy Afterloaders, Brachytherapy Seeds market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Brachytherapy Afterloaders, Brachytherapy Seeds for these regions, from 2012 to 2022 (forecast) -......
  • Global Anti-inflammatory Therapeutics Market 2017-2021
    Published: 14-Jun-2017        Price: US 3500 Onwards        Pages: 98
    Inflammation is a part of immune response triggered against harmful stimuli, foreign objects, damaged cells, irritants, and pathogens in the body. The drugs used to treat these symptoms are called anti-inflammatory drugs. It causes the elimination of the initial cause of cell injury, clearance of dead or necrotic cells, and damaged tissue from the site of the inflammatory process and initiates tissue repair. The analysts forecast global anti-inflammatory therapeutics market to grow at......
  • Global Substance Abuse Treatment Market 2017-2021
    Published: 14-Jun-2017        Price: US 3500 Onwards        Pages: 73
    Substance abuse is defined as an illicit use of alcohol, drugs, or cigarettes. They are potentially addictive in nature, difficult to treat, and have a negative impact on body and overall health. The major factors driving the market is the increase in substance usage and the number of associated deaths. It is also identified as a high economic burden. Substance abuse is one of the primary causes of death globally and a major economic burden. Substance abuse, along with addiction is associated......
  • United States Varicose Vein Treatment Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 13-Jun-2017        Price: US 4480 Onwards        Pages: 118
    There are several treatment options for Varicose Veins, wearing support stockings, Varicose Vein Treatment Devices; endogenous laser treatment, radiofrequency occlusion, surgery, and lasers and intense pulsed light. Mentioning medical devices for treating Varicose Veins, there is mainly Laser devices, Trivex and RFITT system. Scope of the Report: This report focuses on the Varicose Vein Treatment in United States market, to split the market based on manufacturers, states, ......
  • Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2017
    Published: 13-Jun-2017        Price: US 2000 Onwards        Pages: 35
    Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2017, provides an overview of the Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline landscape. Metachromatic leukodystrophy is an inherited disorder characterized by the accumulation of fats called sulfatides in cells. Symptoms......
  • Canavan Disease - Pipeline Review, H1 2017
    Published: 13-Jun-2017        Price: US 2000 Onwards        Pages: 25
    Canavan Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Pipeline Review, H1 2017, provides an overview of the Canavan Disease (Central Nervous System) pipeline landscape. Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutation in the gene ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs